Free Trial

Antibe Therapeutics Q2 2024 Earnings Report

Antibe Therapeutics EPS Results

Actual EPS
-C$0.10
Consensus EPS
-C$0.12
Beat/Miss
Beat by +C$0.02
One Year Ago EPS
N/A

Antibe Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Antibe Therapeutics Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

Antibe Therapeutics Earnings Headlines

70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!
Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.
Antibe Extends Early Warrant Exercise Incentive Program
Antibe Therapeutics Inc ATE
See More Antibe Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Antibe Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Antibe Therapeutics and other key companies, straight to your email.

About Antibe Therapeutics

Antibe Therapeutics (TSE:ATE), a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's pipeline includes therapies that seek to overcome the gastrointestinal (GI) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead compound is Otenaproxesul, an NSAID that releases hydrogen sulfide for treating post-operative pain, migraine, acute musculoskeletal pain, dysmenorrhea, gout, and dental pain. In addition, its products comprise ATB-352, which is in preclinical stage for acute pain. The company was incorporated in 2009 and is headquartered in Toronto, Canada.

View Antibe Therapeutics Profile

More Earnings Resources from MarketBeat

Upcoming Earnings